The Atrial Natriuretic Peptide-to-brain Natriuretic Peptide Ratio Predicts Left Atrial Reverse Remodeling after Rhythm Control Therapy in Patients with Persistent Atrial Fibrillation

Objective The association between natriuretic peptide levels in atrial fibrillation (AF) patients with advanced left atrial (LA) remodeling and reverse remodeling after rhythm control therapy has not been clarified. The present study assessed the role of atrial natriuretic peptide (ANP) and brain na...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Internal Medicine 2023/11/15, Vol.62(22), pp.3283-3290
Hauptverfasser: Hasegawa, Yuki, Okada, Shinsuke, Sanada, Akiko, Tomii, Asako, Sugiura, Hirotaka, Higuchi, Kotaro, Chinushi, Masaomi, Inomata, Takayuki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3290
container_issue 22
container_start_page 3283
container_title Internal Medicine
container_volume 62
creator Hasegawa, Yuki
Okada, Shinsuke
Sanada, Akiko
Tomii, Asako
Sugiura, Hirotaka
Higuchi, Kotaro
Chinushi, Masaomi
Inomata, Takayuki
description Objective The association between natriuretic peptide levels in atrial fibrillation (AF) patients with advanced left atrial (LA) remodeling and reverse remodeling after rhythm control therapy has not been clarified. The present study assessed the role of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) measurements to predict LA reverse remodeling after catheter ablation (CA) in persistent AF patients with LA enlargement. Methods This study included 88 persistent AF patients with LA enlargement (volume index >48 mL/m2) who underwent CA. Plasma ANP and BNP levels were analyzed before CA in all patients. The study population was divided into 2 groups according to the extent of decrease in the LA volume index (LAVI) at 6 months after CA responders were those with a ≥15% reduction in the LAVI, and all others were non-responders. Results At follow-up, 58 patients (66%) were classified as responders. The preprocedural ANP level was significantly higher in the responders than in the non-responders (p=0.03). Furthermore, the ANP-to-BNP ratio (ANP/BNP) was significantly higher in the responders than in the non-responders (p
doi_str_mv 10.2169/internalmedicine.1478-22
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10713385</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2780078746</sourcerecordid><originalsourceid>FETCH-LOGICAL-c587t-c1f400310b599533321b310dd2638c860557ab5e6cd81390a31610690cb6f8853</originalsourceid><addsrcrecordid>eNptkttuEzEQhlcIRNPCKyBL3HCzxYfsrn2FqqilSBGNonJteb2zWUebdbCdorwYz8csOQgKNx7Z_v39M57JMsLoNWel-uiGBGEw_QYaZ90A12xayZzzF9mEianKKy6Kl9mEKoanuFxklzGuKRWyUvx1diFKyQWVdJL9fOyA3KTgTE--Goy7AMlZsoBtcg3kyed1MG743yVZmuQ8WYQxixTJHNp0Yi3hCUJECWx8A70bVsS0mDRZdvvUbcjMDyn4nqB9MNs9QYcF0mBAzg-XOvQI0cWEByfknauD6_vRc3iTvWpNH-HtMV5l3-5uH2f3-fzh85fZzTy3haxSblk7xaoZrQulCiEEZzXumoaXQlpZ0qKoTF1AaRvJhKJGsJLRUlFbl62UhbjKPh24212Nn20xnWB6vQ1uY8Jee-P03zeD6_TKP2lGKybEb8KHIyH47zuISW9ctIB1DOB3UfNKUlrJalqi9P0z6drvxjajSlGmqkKJESgPKht8jAHaczaM6nE69PPp0ON0aM7x6bs_qzk_PI0DCh4OgnVMZgVngQnY9h7-JZccueN6tDgrbWeChkH8AitP3B8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2901975935</pqid></control><display><type>article</type><title>The Atrial Natriuretic Peptide-to-brain Natriuretic Peptide Ratio Predicts Left Atrial Reverse Remodeling after Rhythm Control Therapy in Patients with Persistent Atrial Fibrillation</title><source>J-STAGE Free</source><source>MEDLINE</source><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Hasegawa, Yuki ; Okada, Shinsuke ; Sanada, Akiko ; Tomii, Asako ; Sugiura, Hirotaka ; Higuchi, Kotaro ; Chinushi, Masaomi ; Inomata, Takayuki</creator><creatorcontrib>Hasegawa, Yuki ; Okada, Shinsuke ; Sanada, Akiko ; Tomii, Asako ; Sugiura, Hirotaka ; Higuchi, Kotaro ; Chinushi, Masaomi ; Inomata, Takayuki</creatorcontrib><description>Objective The association between natriuretic peptide levels in atrial fibrillation (AF) patients with advanced left atrial (LA) remodeling and reverse remodeling after rhythm control therapy has not been clarified. The present study assessed the role of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) measurements to predict LA reverse remodeling after catheter ablation (CA) in persistent AF patients with LA enlargement. Methods This study included 88 persistent AF patients with LA enlargement (volume index &gt;48 mL/m2) who underwent CA. Plasma ANP and BNP levels were analyzed before CA in all patients. The study population was divided into 2 groups according to the extent of decrease in the LA volume index (LAVI) at 6 months after CA responders were those with a ≥15% reduction in the LAVI, and all others were non-responders. Results At follow-up, 58 patients (66%) were classified as responders. The preprocedural ANP level was significantly higher in the responders than in the non-responders (p=0.03). Furthermore, the ANP-to-BNP ratio (ANP/BNP) was significantly higher in the responders than in the non-responders (p&lt;0.01). The ANP/BNP was correlated with the percentage decrease in the LAVI (r=0.391, p&lt;0.01). A multivariate linear regression analysis revealed that the ANP/BNP before CA was an independent predictor of LA reverse remodeling (p&lt;0.01). Conclusion The preprocedural ANP/BNP was a robust predictor of reverse remodeling of the enlarged LA after sinus rhythm restoration by rhythm control therapy in persistent AF patients.</description><identifier>ISSN: 0918-2918</identifier><identifier>EISSN: 1349-7235</identifier><identifier>DOI: 10.2169/internalmedicine.1478-22</identifier><identifier>PMID: 36823080</identifier><language>eng</language><publisher>Japan: The Japanese Society of Internal Medicine</publisher><subject>Atrial Fibrillation ; Atrial Natriuretic Factor ; Atrial natriuretic peptide ; Brain natriuretic peptide ; Cardiac arrhythmia ; catheter ablation ; Enlargement ; Fibrillation ; Humans ; Internal medicine ; Linear Models ; Multivariate Analysis ; Natriuretic Peptide, Brain ; Original ; Peptides ; Population studies ; reverse remodeling</subject><ispartof>Internal Medicine, 2023/11/15, Vol.62(22), pp.3283-3290</ispartof><rights>2023 by The Japanese Society of Internal Medicine</rights><rights>Copyright Japan Science and Technology Agency 2023</rights><rights>Copyright © 2023 by The Japanese Society of Internal Medicine</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c587t-c1f400310b599533321b310dd2638c860557ab5e6cd81390a31610690cb6f8853</citedby><cites>FETCH-LOGICAL-c587t-c1f400310b599533321b310dd2638c860557ab5e6cd81390a31610690cb6f8853</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10713385/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10713385/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,1876,27903,27904,53770,53772</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36823080$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hasegawa, Yuki</creatorcontrib><creatorcontrib>Okada, Shinsuke</creatorcontrib><creatorcontrib>Sanada, Akiko</creatorcontrib><creatorcontrib>Tomii, Asako</creatorcontrib><creatorcontrib>Sugiura, Hirotaka</creatorcontrib><creatorcontrib>Higuchi, Kotaro</creatorcontrib><creatorcontrib>Chinushi, Masaomi</creatorcontrib><creatorcontrib>Inomata, Takayuki</creatorcontrib><title>The Atrial Natriuretic Peptide-to-brain Natriuretic Peptide Ratio Predicts Left Atrial Reverse Remodeling after Rhythm Control Therapy in Patients with Persistent Atrial Fibrillation</title><title>Internal Medicine</title><addtitle>Intern. Med.</addtitle><description>Objective The association between natriuretic peptide levels in atrial fibrillation (AF) patients with advanced left atrial (LA) remodeling and reverse remodeling after rhythm control therapy has not been clarified. The present study assessed the role of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) measurements to predict LA reverse remodeling after catheter ablation (CA) in persistent AF patients with LA enlargement. Methods This study included 88 persistent AF patients with LA enlargement (volume index &gt;48 mL/m2) who underwent CA. Plasma ANP and BNP levels were analyzed before CA in all patients. The study population was divided into 2 groups according to the extent of decrease in the LA volume index (LAVI) at 6 months after CA responders were those with a ≥15% reduction in the LAVI, and all others were non-responders. Results At follow-up, 58 patients (66%) were classified as responders. The preprocedural ANP level was significantly higher in the responders than in the non-responders (p=0.03). Furthermore, the ANP-to-BNP ratio (ANP/BNP) was significantly higher in the responders than in the non-responders (p&lt;0.01). The ANP/BNP was correlated with the percentage decrease in the LAVI (r=0.391, p&lt;0.01). A multivariate linear regression analysis revealed that the ANP/BNP before CA was an independent predictor of LA reverse remodeling (p&lt;0.01). Conclusion The preprocedural ANP/BNP was a robust predictor of reverse remodeling of the enlarged LA after sinus rhythm restoration by rhythm control therapy in persistent AF patients.</description><subject>Atrial Fibrillation</subject><subject>Atrial Natriuretic Factor</subject><subject>Atrial natriuretic peptide</subject><subject>Brain natriuretic peptide</subject><subject>Cardiac arrhythmia</subject><subject>catheter ablation</subject><subject>Enlargement</subject><subject>Fibrillation</subject><subject>Humans</subject><subject>Internal medicine</subject><subject>Linear Models</subject><subject>Multivariate Analysis</subject><subject>Natriuretic Peptide, Brain</subject><subject>Original</subject><subject>Peptides</subject><subject>Population studies</subject><subject>reverse remodeling</subject><issn>0918-2918</issn><issn>1349-7235</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkttuEzEQhlcIRNPCKyBL3HCzxYfsrn2FqqilSBGNonJteb2zWUebdbCdorwYz8csOQgKNx7Z_v39M57JMsLoNWel-uiGBGEw_QYaZ90A12xayZzzF9mEianKKy6Kl9mEKoanuFxklzGuKRWyUvx1diFKyQWVdJL9fOyA3KTgTE--Goy7AMlZsoBtcg3kyed1MG743yVZmuQ8WYQxixTJHNp0Yi3hCUJECWx8A70bVsS0mDRZdvvUbcjMDyn4nqB9MNs9QYcF0mBAzg-XOvQI0cWEByfknauD6_vRc3iTvWpNH-HtMV5l3-5uH2f3-fzh85fZzTy3haxSblk7xaoZrQulCiEEZzXumoaXQlpZ0qKoTF1AaRvJhKJGsJLRUlFbl62UhbjKPh24212Nn20xnWB6vQ1uY8Jee-P03zeD6_TKP2lGKybEb8KHIyH47zuISW9ctIB1DOB3UfNKUlrJalqi9P0z6drvxjajSlGmqkKJESgPKht8jAHaczaM6nE69PPp0ON0aM7x6bs_qzk_PI0DCh4OgnVMZgVngQnY9h7-JZccueN6tDgrbWeChkH8AitP3B8</recordid><startdate>20231115</startdate><enddate>20231115</enddate><creator>Hasegawa, Yuki</creator><creator>Okada, Shinsuke</creator><creator>Sanada, Akiko</creator><creator>Tomii, Asako</creator><creator>Sugiura, Hirotaka</creator><creator>Higuchi, Kotaro</creator><creator>Chinushi, Masaomi</creator><creator>Inomata, Takayuki</creator><general>The Japanese Society of Internal Medicine</general><general>Japan Science and Technology Agency</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20231115</creationdate><title>The Atrial Natriuretic Peptide-to-brain Natriuretic Peptide Ratio Predicts Left Atrial Reverse Remodeling after Rhythm Control Therapy in Patients with Persistent Atrial Fibrillation</title><author>Hasegawa, Yuki ; Okada, Shinsuke ; Sanada, Akiko ; Tomii, Asako ; Sugiura, Hirotaka ; Higuchi, Kotaro ; Chinushi, Masaomi ; Inomata, Takayuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c587t-c1f400310b599533321b310dd2638c860557ab5e6cd81390a31610690cb6f8853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Atrial Fibrillation</topic><topic>Atrial Natriuretic Factor</topic><topic>Atrial natriuretic peptide</topic><topic>Brain natriuretic peptide</topic><topic>Cardiac arrhythmia</topic><topic>catheter ablation</topic><topic>Enlargement</topic><topic>Fibrillation</topic><topic>Humans</topic><topic>Internal medicine</topic><topic>Linear Models</topic><topic>Multivariate Analysis</topic><topic>Natriuretic Peptide, Brain</topic><topic>Original</topic><topic>Peptides</topic><topic>Population studies</topic><topic>reverse remodeling</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hasegawa, Yuki</creatorcontrib><creatorcontrib>Okada, Shinsuke</creatorcontrib><creatorcontrib>Sanada, Akiko</creatorcontrib><creatorcontrib>Tomii, Asako</creatorcontrib><creatorcontrib>Sugiura, Hirotaka</creatorcontrib><creatorcontrib>Higuchi, Kotaro</creatorcontrib><creatorcontrib>Chinushi, Masaomi</creatorcontrib><creatorcontrib>Inomata, Takayuki</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Internal Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hasegawa, Yuki</au><au>Okada, Shinsuke</au><au>Sanada, Akiko</au><au>Tomii, Asako</au><au>Sugiura, Hirotaka</au><au>Higuchi, Kotaro</au><au>Chinushi, Masaomi</au><au>Inomata, Takayuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Atrial Natriuretic Peptide-to-brain Natriuretic Peptide Ratio Predicts Left Atrial Reverse Remodeling after Rhythm Control Therapy in Patients with Persistent Atrial Fibrillation</atitle><jtitle>Internal Medicine</jtitle><addtitle>Intern. Med.</addtitle><date>2023-11-15</date><risdate>2023</risdate><volume>62</volume><issue>22</issue><spage>3283</spage><epage>3290</epage><pages>3283-3290</pages><artnum>1478-22</artnum><issn>0918-2918</issn><eissn>1349-7235</eissn><abstract>Objective The association between natriuretic peptide levels in atrial fibrillation (AF) patients with advanced left atrial (LA) remodeling and reverse remodeling after rhythm control therapy has not been clarified. The present study assessed the role of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) measurements to predict LA reverse remodeling after catheter ablation (CA) in persistent AF patients with LA enlargement. Methods This study included 88 persistent AF patients with LA enlargement (volume index &gt;48 mL/m2) who underwent CA. Plasma ANP and BNP levels were analyzed before CA in all patients. The study population was divided into 2 groups according to the extent of decrease in the LA volume index (LAVI) at 6 months after CA responders were those with a ≥15% reduction in the LAVI, and all others were non-responders. Results At follow-up, 58 patients (66%) were classified as responders. The preprocedural ANP level was significantly higher in the responders than in the non-responders (p=0.03). Furthermore, the ANP-to-BNP ratio (ANP/BNP) was significantly higher in the responders than in the non-responders (p&lt;0.01). The ANP/BNP was correlated with the percentage decrease in the LAVI (r=0.391, p&lt;0.01). A multivariate linear regression analysis revealed that the ANP/BNP before CA was an independent predictor of LA reverse remodeling (p&lt;0.01). Conclusion The preprocedural ANP/BNP was a robust predictor of reverse remodeling of the enlarged LA after sinus rhythm restoration by rhythm control therapy in persistent AF patients.</abstract><cop>Japan</cop><pub>The Japanese Society of Internal Medicine</pub><pmid>36823080</pmid><doi>10.2169/internalmedicine.1478-22</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0918-2918
ispartof Internal Medicine, 2023/11/15, Vol.62(22), pp.3283-3290
issn 0918-2918
1349-7235
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10713385
source J-STAGE Free; MEDLINE; PubMed Central Open Access; PubMed Central
subjects Atrial Fibrillation
Atrial Natriuretic Factor
Atrial natriuretic peptide
Brain natriuretic peptide
Cardiac arrhythmia
catheter ablation
Enlargement
Fibrillation
Humans
Internal medicine
Linear Models
Multivariate Analysis
Natriuretic Peptide, Brain
Original
Peptides
Population studies
reverse remodeling
title The Atrial Natriuretic Peptide-to-brain Natriuretic Peptide Ratio Predicts Left Atrial Reverse Remodeling after Rhythm Control Therapy in Patients with Persistent Atrial Fibrillation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T06%3A45%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Atrial%20Natriuretic%20Peptide-to-brain%20Natriuretic%20Peptide%20Ratio%20Predicts%20Left%20Atrial%20Reverse%20Remodeling%20after%20Rhythm%20Control%20Therapy%20in%20Patients%20with%20Persistent%20Atrial%20Fibrillation&rft.jtitle=Internal%20Medicine&rft.au=Hasegawa,%20Yuki&rft.date=2023-11-15&rft.volume=62&rft.issue=22&rft.spage=3283&rft.epage=3290&rft.pages=3283-3290&rft.artnum=1478-22&rft.issn=0918-2918&rft.eissn=1349-7235&rft_id=info:doi/10.2169/internalmedicine.1478-22&rft_dat=%3Cproquest_pubme%3E2780078746%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2901975935&rft_id=info:pmid/36823080&rfr_iscdi=true